Influences of CYP2D6*10 polymorphisms on the pharmacokinetics of iloperidone and its metabolites in Chinese patients with schizophrenia: a population pharmacokinetic analysis

被引：0
|
作者：
Qi Pei
Lu Huang
Jie Huang
Jing-kai Gu
Yun Kuang
Xiao-cong Zuo
Jun-jie Ding
Hong-yi Tan
Cheng-xian Guo
Shi-kun Liu
Guo-ping Yang
机构：
[1] Third Xiangya Hospital,Center of Clinical Pharmacology and Pharmacy Department
[2] Central South University,undefined
[3] Drug Metabolism Research Center of Jilin University,undefined
[4] Children's Hospital of Fudan University,undefined
来源：
Acta Pharmacologica Sinica | 2016年 / 37卷
关键词：
schizophrenia; iloperidone; gene polymorphisms; 10; population pharmacokinetics;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1499 / 1508
页数：9
相关论文
共 50 条
  • [21] Effect of CYP2D6*10 allele on the pharmacokinetics of loratadine in Chinese subjects
    Yin, OQP
    Shi, XJ
    Tomlinson, B
    Chow, MSS
    DRUG METABOLISM AND DISPOSITION, 2005, 33 (09) : 1283 - 1287
  • [22] Influence of CYP2D6 gene polymorphisms on the pharmacokinetics of aripiprazole in healthy Chinese subjects
    Zhang, Xiaodan
    Liu, Chengquan
    Zhou, Shuang
    Xie, Ran
    He, Xu
    Wang, Zhiqi
    Yi, Honghong
    Shu, You
    Wang, Zining
    Hu, Kun
    Ma, Lingyue
    Cui, Yimin
    Zhao, Xia
    Xiang, Jin
    PHARMACOGENOMICS, 2021, 22 (04) : 213 - 223
  • [23] Evaluation of the effect of CYP2D6*3,*4,*10, and*17 polymorphisms on the pharmacokinetic of tamoxifen and its metabolites in patients with hormone-positive breast cancer
    Saghafi, Fatemeh
    Salehifar, Ebrahim
    Ebrahimi, Pouneh
    Shiran, Mohammad Reza
    Zaboli, Ehsan
    Sohrevardi, Seyed Mojtaba
    Jamialahmadi, Tannaz
    Sahebnasagh, Adeleh
    Sahebkar, Amirhossein
    JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS, 2024, 238
  • [24] Genetic polymorphisms of CYP2D6 in Chinese mainland
    Ji, L
    Pan, SX
    Wu, JM
    Marti-Jaun, J
    Hersberger, M
    CHINESE MEDICAL JOURNAL, 2002, 115 (12) : 1780 - 1784
  • [25] Effects of CYP3A5 and CYP2D6 genetic polymorphism on the pharmacokinetics of diltiazem and its metabolites in Chinese subjects
    Zheng, T.
    Su, C. H.
    Zhao, J.
    Zhang, X. J.
    Zhang, T. Y.
    Zhang, L. R.
    Kan, Q. C.
    Zhang, S. J.
    PHARMAZIE, 2013, 68 (04): : 257 - 260
  • [26] The association between CYP2D6 genetic polymorphism and schizophrenia in a Chinese population
    Zhou, Jian
    Wang Yajie
    Wang, Gang
    Chen Xueyan
    Lv, Hong
    Kang Xixiong
    PROGRESS ON POST-GENOME TECHNOLOGIES, 2007, : 453 - 455
  • [27] CYP2D6 polymorphisms in patients with porphyrias
    Lavandera, Jimena V.
    Parera, Victoria E.
    Batlle, Alcira
    Buzaleh, Ana Maria
    MOLECULAR MEDICINE, 2006, 12 (9-10) : 259 - 263
  • [28] CYP2D6 Polymorphisms in Patients with Porphyrias
    Jimena V. Lavandera
    Victoria E. Parera
    Alcira Batlle
    Ana María Buzaleh
    Molecular Medicine, 2006, 12 : 259 - 263
  • [29] Frequency of CYP2D6*10 and *14 alleles and their influence on the metabolic activity of CYP2D6 in a healthy Chinese population
    Cai, W. M.
    Chen, B.
    Zhang, W. X.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2007, 81 (01) : 95 - 98
  • [30] Assessment of Activity Levels for CYP2D6*1, CYP2D6*2, and CYP2D6*41 Genes by Population Pharmacokinetics of Dextromethorphan
    Abduljalil, K.
    Frank, D.
    Gaedigk, A.
    Klaassen, T.
    Tomalik-Scharte, D.
    Jetter, A.
    Jaehde, U.
    Kirchheiner, J.
    Fuhr, U.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2010, 88 (05) : 643 - 651
12345